veterinary drug

Hemophyt®

Film-coated tablet containing phytomenadione (Ph. Eur.), a vitamin K1 used as an antidote following the ingestion of vitamin K antagonist anticoagulants in dogs.

Active ingredient:Phytoménadione (Vitamin K1)
  • Concentration: 50 mg/tablet
  • Administration : oral
  • Dosage: 5 mg/kg once daily for a minimum of 21 days (1 tablet per 10 kg per day).
Box contents:12 x 7 comprimés
Part of the range

Indications

  • For the maintenance treatment of anticoagulant poisoning in dogs following emergency parenteral treatment with vitamin K1 in the presence of clinical coagulopathy 1 ;
  • As the sole agent for the treatment of subclinical coagulopathy caused by anticoagulant intoxication.

How to administer Hemophyt®?

  • Each tablet contains 50mg of phytomenadione (vitamin K1).
  • For oral use at 5 mg/kg once daily for a minimum of 21 days (1 tablet per 10 kg).
  • Administer the tablets 30 to 60 minutes after a meal.
  • Tablets that can be broken into halves and quarters.
  • Store between 15-30°C in the original packaging, protected from light. Any unused portion of tablets should be discarded after 3 days.

Specifications

Regulatory

  • DIN: DIN 02539314
  • Prescription required (Canada): Yes
  • Prescription required (Quebec): Yes
  • WHMIS: No
  • Cytotoxic: No

Physics

  • Package length: 11.3 cm
  • Packaging width: 9.9 cm
  • Packaging height: 5.3 cm
  • Package weight: 0.13 kg
  • Unilingual packaging: No

¹Clinical coagulopathy is defined as the presence of bleeding that may occur at one or more sites, associated with a prolonged prothrombin time (PT) phase.
Subclinical coagulopathy is defined as mild coagulopathy (≥ 20% increase in the upper reference range of PT) occurring in the early phase of anticoagulant poisoning, when dogs show no clinical signs.